You are here

  • Home
  • Archive
  • Volume 61, Issue 1
  • Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy

Article info

Article menu
Download PDFPDF
Original article
Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy

Authors

  1. Professor J Rüschoff, Institute of Pathology, Nordhessen, Germany; rueschoff{at}patho-nordhessen.de
View Full Text

Citation

Hofmann M, Stoss O, Gaiser T, et al
Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy
Journal of Clinical Pathology 2008;61:89-94.

Publication history

  • Accepted March 7, 2007
  • First published April 5, 2007.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 The BMJ Publishing Group and the Association of Clinical Pathologists